IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regulus Therapeutics Inc

CUSIP: 75915K200 | 96 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

NEA Management Company, LLC6,467,802
0.9% of portfolio›$11.6M
StyleTurnoverLocationFiled
NEA Management Company, LLC
6,467,802$11.6M0.9%Deep ValueLowTimonium, MD2024-08-14